ERK1-Mediated Immunomodulation of Mesenchymal Stem Cells Ameliorates Inflammatory Disorders

The authors indicated that ERK1-/- BMMSCs, but not ERK2-/- bone marrow MSCs, failed to promote T cell apoptosis due to incapacity to activate the ETS2/AURKA/NFκB/Fas/MCP-1 cascade.